Arkolith/Insider Trading/SGP/Form 4

Pardo Geoffrey B

DirectorSpyGlass Pharma, Inc. (SGP) · full profile →Form 4 · filed Feb 11, 2026
Net Buying
Open-Market Buys
$5.0M
Open-Market Sells
$0
Net Open-Market Flow
$5.0M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 9, 2026Conversion(C)1.9M—$01.9M
Feb 9, 2026Buy(P)313K$16.00$5.0M2.2M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 9, 2026Conversion(C)1.9M——0

Transaction Codes

C
Conversion of a derivative
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001753143-26-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for SpyGlass Pharma, Inc.

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp